MEDNAX (MD) Tops Q3 EPS by 7c, Beats on Revenue; Reaffirms EBITDA Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. INSP
9. CVI
10. HNGE

Go back to MEDNAX (MD) Tops Q3 EPS by 7c, Beats on Revenue; Reaffirms EBITDA Guidance

Pediatrix Medical Group Reports Third Quarter Results

October 29, 2026 6:00 AM EDT

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.59 per share for the three months ended September 30, 2026. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.72.

For the 2026 third quarter, Pediatrix reported the following results:

Net revenue of $501 million; Net income of $47 million; and Adjusted EBITDA of $85 million.

We are pleased with our results this quarter, driven by both volume and pricing performing ahead of our expectations, said Mark S. Ordan, Chief... More